| Patent | Date |
|---|
Macrocyclic Mcl-1 Inhibitors And Methods Of Use
App 20220259226 - Braje; Wilfried ; et al. | 2022-08-18 |
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20210346369 - WANG; Le ; et al. | 2021-11-11 |
Macrocyclic Mcl-1 Inhibitors And Methods Of Use
App 20210292339 - BRAJE; Wilfried ; et al. | 2021-09-23 |
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20210228565 - Wang; Le ; et al. | 2021-07-29 |
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20200345717 - WANG; Le ; et al. | 2020-11-05 |
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20200253954 - Kind Code | 2020-08-13 |
Macrocyclic Mcl-1 Inhibitors And Methods Of Use
App 20200255451 - Kind Code | 2020-08-13 |
BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same
App 20200246460 - Kind Code | 2020-08-06 |
Antibody Drug Conjugates with Cell Permeable BCL-XL Inhibitors
App 20200246323 - Kind Code | 2020-08-06 |
BCL-XL Inhibitory Compounds and Antibody Drug Conjugates Including the Same
App 20200239553 - Ackler; Scott L. ; et al. | 2020-07-30 |
Macrocyclic Mcl-1 Inhibitors And Methods Of Use
App 20200239494 - BRAJE; Wilfried ; et al. | 2020-07-30 |
Anti-b7-h3 Antibodies And Antibody Drug Conjugates
App 20200002421 - Benatuil; Lorenzo ; et al. | 2020-01-02 |
Anti-cd98 Antibodies And Antibody Drug Conjugates
App 20200002432 - Benatuil; Lorenzo ; et al. | 2020-01-02 |
Anti-egfr Antibody Drug Conjugates
App 20190153107 - Boghaert; Erwin R. ; et al. | 2019-05-23 |
BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same
App 20190142941 - Ackler; Scott L. ; et al. | 2019-05-16 |
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20180221363 - WANG; Le ; et al. | 2018-08-09 |
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20180140595 - Wang; Le ; et al. | 2018-05-24 |
Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases
Grant 9,877,958 - Wang , et al. January 30, 2 | 2018-01-30 |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 9,844,547 - Wang , et al. December 19, 2 | 2017-12-19 |
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20170296531 - Wang; Le ; et al. | 2017-10-19 |
Antibody Drug Conjugates with Cell Permeable BCL-XL Inhibitors
App 20170182179 - Ackler; Scott L. ; et al. | 2017-06-29 |
Nampt Inhibitors
App 20170135994 - Clark; Richard F. ; et al. | 2017-05-18 |
Nampt Inhibitors
App 20170065575 - Hansen; Todd M. ; et al. | 2017-03-09 |
BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same
App 20160339117 - Ackler; Scott L. ; et al. | 2016-11-24 |
Apoptosis-induced Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20160206611 - Wang; Le ; et al. | 2016-07-21 |
Nampt Inhibitors
App 20160184281 - Clark; Richard F. ; et al. | 2016-06-30 |
Nampt Inhibitors
App 20160184282 - Clark; Richard F. ; et al. | 2016-06-30 |
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20160158218 - Wang; Le ; et al. | 2016-06-09 |
BCL-XL Inhibitory Compounds and Antibody Drug Conjugates Including the Same
App 20160158377 - Ackler; Scott L. ; et al. | 2016-06-09 |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 9,266,877 - Wang , et al. February 23, 2 | 2016-02-23 |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 9,227,963 - Wang , et al. January 5, 2 | 2016-01-05 |
NAMPT inhibitors
Grant 9,193,723 - Clark , et al. November 24, 2 | 2015-11-24 |
NAMPT inhibitors
Grant 9,187,472 - Clark , et al. November 17, 2 | 2015-11-17 |
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20150152097 - Wang; Le ; et al. | 2015-06-04 |
Nampt Inhibitors
App 20150141398 - Hansen; Todd M. ; et al. | 2015-05-21 |
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20150072978 - Wang; Le ; et al. | 2015-03-12 |
NAMPT inhibitors
Grant 8,975,398 - Hansen , et al. March 10, 2 | 2015-03-10 |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 8,940,737 - Wang , et al. January 27, 2 | 2015-01-27 |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 8,889,675 - Wang , et al. November 18, 2 | 2014-11-18 |
Lactam acetamides as calcium channel blockers
Grant 8,815,869 - Drizin , et al. August 26, 2 | 2014-08-26 |
Nampt Inhibitors
App 20130303510 - Hansen; Todd M. ; et al. | 2013-11-14 |
Nampt Inhibitors
App 20130303508 - Clark; Richard F. ; et al. | 2013-11-14 |
Nampt Inhibitors
App 20130303511 - Clark; Richard F. ; et al. | 2013-11-14 |
Nampt Inhibitors
App 20130303509 - Hansen; Todd M. ; et al. | 2013-11-14 |
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20130096121 - Wang; Le ; et al. | 2013-04-18 |
Apoptosis-induced Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20130096120 - WANG; LE ; et al. | 2013-04-18 |
4-substituted Phenoxyphenylacetic Acid Derivatives
App 20120202854 - Doherty; George ; et al. | 2012-08-09 |
4-substituted phenoxyphenylacetic acid derivatives
Grant 8,183,289 - Doherty , et al. May 22, 2 | 2012-05-22 |
Lactam Acetamides As Calcium Channel Blockers
App 20110230459 - Drizin; Irene ; et al. | 2011-09-22 |
4-substituted Phenoxyphenylacetic Acid Derivatives
App 20100173955 - Doherty; George ; et al. | 2010-07-08 |
Substituted N-arylsulfonyl-proline derivatives as potent cell adhesion inhibitors
Grant 6,943,180 - Doherty , et al. September 13, 2 | 2005-09-13 |
N-arylsulfonyl aza-bicyclic derivatives as potent cell adhesion inhibitors
Grant 6,855,708 - Lin , et al. February 15, 2 | 2005-02-15 |
Substituted n-arylsulfonyl-proline derivatives as potent cell adhesion inhibitors
App 20040102478 - Doherty, George ; et al. | 2004-05-27 |
N-arylsulfonyl aza-bicyclic derivatives as potent cell adhesion inhibitors
App 20030008861 - Lin, Linus S. ; et al. | 2003-01-09 |
Heterocycle amides as cell adhesion inhibitors
Grant 6,420,418 - Hagmann , et al. July 16, 2 | 2002-07-16 |
| 